Anistreplase
N/A
Report date: 2022/05/16 18:00:14
NME
Base Information
Drug NameAnistreplase
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSigma-Tau SpaGlaxosmithkline Plc
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksWikipedia